FLUIDIA Overview
- Founded
- 2016
- Status
- Private
- Latest Deal Type
- Crowdfunding
- Latest Deal Amount
- $197K
FLUIDIA General Information
Description
Developer of multi-protein diagnostic tests designed to be used for the early diagnosis of human diseases. The company's tests include immunoenzymatic test that allows the quantitative assay of the whole and phosphorylated form of Raf Kinase Inhibitor Protein in any biological sample, enabling pathologists and biologists to develop new technological methods for precision medicine.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- Policlinico di Bari
- Piazza Giulio Cesare, 11
- 71124 Bari
- Italy
FLUIDIA Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Equity Crowdfunding | 23-Jun-2018 | $197K | 00.000 | Completed | Generating Revenue |
FLUIDIA Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Nicola Marino | Chief Operating Officer | ||
| Elena Ranieri Ph.D | Co-Founder | ||
| Massimo Papale Ph.D | Co-Founder |